No Excess Pregnancy, Infant Risks With Ocrelizumab for MS

(MedPage Today) -- Women with multiple sclerosis (MS) who were treated with ocrelizumab (Ocrevus) had no increased risk of adverse pregnancy and infant outcomes, prospective data showed.
Cumulative data did not suggest an increased risk of preterm...